Medical Devices US

US Airway Management Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Airway Management Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Type of Device, By Application, By Material Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $866.9 Mn Placeholder estimate
Estimate 2025 $894.6 Mn 40.4% of the global market
Projected 2034 $1.19 Bn 32.8% Adds $293.2 Mn over 9 forecast years
CAGR 2025–2034 3.2% Faster than 6% of 173 Medical Devices markets here
Key players 6 +1
  • US is 40.42% of the global market.
  • In North America, the largest is US (this report) at $894.6 Mn.
  • Fastest growing: Canada at 5.2% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$293.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Airway Management Devices Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $866.9 Mn — —
2025 (base) $894.6 Mn +$27.7 Mn —
2026 (forecast) $923.2 Mn +$28.6 Mn +3.2%
2027 (forecast) $952.8 Mn +$29.5 Mn +6.5%
2028 (forecast) $983.3 Mn +$30.5 Mn +9.9%
2029 (forecast) $1.01 Bn +$31.5 Mn +13.4%
2030 (forecast) $1.05 Bn +$32.5 Mn +17.1%
2031 (forecast) $1.08 Bn +$33.5 Mn +20.8%
2032 (forecast) $1.12 Bn +$34.6 Mn +24.7%
2033 (forecast) $1.15 Bn +$35.7 Mn +28.7%
2034 (forecast) $1.19 Bn +$36.8 Mn +32.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Airway Management Devices Market Analysis at a glance
Market size, 2025$894.6 Mn placeholder estimate
Forecast, 2034$1.19 Bn placeholder estimate
Growth (CAGR), 2025–20343.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType of device, application, material type and end user (see all)
Key playersMedtronic, Teleflex Inc, Ambu A/S, Smith’s Medical, Inc., Karl Storz SE & Co. KG and 1 more (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
Active clinical trials318 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Airway Management Devices Market Executive Summary

Airway management entails the assessment, planning and the application of a variety of medical interventions and tools in order to establish the patency or the restoration of airway for effective oxygenation and ventilation. These procedures are required in patients with a compromised airway, respiratory distress, or failure.

Technological development, the growth in diseases affecting the respiratory system, and the growing number of surgical operations are some factors driving the market for airway management devices. The important factors include the necessity for proper management of the airway and new devices like video laryngoscopes which increase safety of surgical and emergency procedures. The market classified by product type includes infraglottic and supraglottic devices, resuscitators and accessories when key companies are Medtronic and Teleflex. Obstacles include legal framework, cost barriers, and a requirement for specialists. As technologies are advancing in the future, some of the impending trends include less invasiveness in surgeries, making of portable devices and integrating artificial intelligence in the healthcare for enhancing both the patient results and the efficacy of the devices.

Bar chart: US Airway Management Devices market size, 2024–2034, placeholder estimates. $866.9 Mn in 2024, $894.6 Mn in 2025 and $1.19 Bn in 2034, 3.2% CAGR.
US Airway Management Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Airway Management Devices Market Dynamics

Market Growth Drivers

The prevalence of respiratory illnesses such as asthma, COPD, and obstructive sleep apnea warrants proper management of airway in order to facilitate adequate oxygenation. An increase in the number of surgeries as a result of a growing population as well as advancement in medical procedures for patients also significantly drives the demand for devices used during operations such as anaesthesia and management of the airway. Concerning the factors that drive the market growth, it has been noted that an increase in the proportion of people aged 65 and above, the prevalence of life-style related disorders including obesity, the growth in the emergency medical transport services, and an emphasis on pediatric care have equally propelled the market’s growth.

Opportunity

Some of the trends in the airway management devices market include identifying new markets such as Asia-Pacific and Latin Americas because of improvements in healthcare and increased purchasing power among patients. Opportunities are present in areas like newer and improved video laryngoscopes, smart monitoring, minimal access options, and disposable products. Also, the ageing apart from having a large population is a specialty care while the specialty care which is pediatrics also shows promising growth.

Market Restraints

Expense, restricted coverage policies, and regulatory requirements can hinder the incorporation of improved airway management devices, particularly in the developing world. Further, the lack of qualified specialists, issues related to risks in potential complications, and restricted acceptance of such technologies can also affect market growth and the usage of these technologies.

Competitive Landscape for Airway Management Devices Market in US

Key Players

Recent Developments

June 2025, Airway Management, leading innovator in sleep therapy products and manufacturer of the most globally researched custom oral appliances, announced the launch of its Morf Nasal CPAP Mask. Designed to enhance comfort and sustainability, this revolutionary mask incorporates a silicone-free biodegradable seal, setting a new standard in the industry.

May 2025, Launch of ALNEST N1 Silent mask. Intended for all patients requiring non-invasive ventilation at home, and more particularly for patients treated with CPAP for Sleep Apnea, this mask has been designed to provide maximum comfort, stability and ease of use. Its landmarks and its silent leak system offer an optimal therapeutic experience.

March 2025, BHV Partners launched Conus Airway, a startup focused on developing medical devices for respiratory tract anesthesia and surgery. These devices enable simultaneous endotracheal dilation and ventilation, aiming to reduce surgical risks, improve outcomes, minimize cross-contamination, and enhance efficiency in managing respiratory surgeries.

May 2021, Olympus received FDA 510(k) clearance for its Airway Mobilescopes (MAF-TM2, MAF-GM2, and MAF-DM2), allowing healthcare providers to perform various upper and lower airway management procedures. These devices are designed for anesthesiologists, pulmonologists, and critical care providers, offering benefits such as portability, digital capture capability, and a compact all-in-one design.

May 2021, Medtronic announced the U.S. commercial launch of the SonarMed airway monitoring system. The system utilises acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time.

Mergers and Acquisitions

March 2024, Medline, a market-leading manufacturer and supplier of medical supplies and solutions, announced successful acquisition of the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd. The compact and intuitive syringe-like device provides an accurate solution for measuring both pressure and volume of airway cuffs in all clinical settings.

October 2025, The Private Equity team advised SunMed Group Holdings d/b/a AirLife, a portfolio company of Frazier Healthcare Partners, on the completion of its acquisition of Avanos Medical, including the BALLARD, MICROCUFF and endOclear product lines.

September 2025, Inogen Completes Acquisition of Physio-Assist. Acquisition expands inogen’s global respiratory care presence by addressing the sizeable, growing and underserved airway clearance market opportunity.

March 2025, Sunmed was to acquire respiratory & anaesthesia consumables business of Vyaire medical.

Healthcare Policies and Regulatory Landscape for Airway Management Devices Market in US

Airway Management Devices in the US: rules, payment and research

The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2] ClinicalTrials.gov lists 318 studies on Airway Management Devices that are recruiting, active or about to start in the US.⁠[3]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

Regulatory approval procedures in developed markets such as the US and Europe demand thorough testing, and this prolongs product development and escalates costs. Standards also change over time, which means that manufacturers will always have to incur costs in order to meet the prevailing ones. Reimbursement has its policies; where there is a favourable coverage policy advocated for establishment of post operative care in fully developed health systems, the absence of such framework in developing markets denies the product due to exorbitant out of pocket expense. Furthermore, possible future adjustments to reimbursement rates and the transition to value-based care initiatives may necessitate cost justification from manufacturers in order to continue growing a lucrative market.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Airway Management Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Airway Management Devices in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Airway Management Devices market in the US?
Placeholder estimate: about $894.6 Mn in 2025, rising to about $1.19 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Airway Management Devices market in the US growing?
Placeholder estimate: about 3.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Airway Management Devices market report cover?
The report splits the market by type of device (Supraglottic Airway Management Devices, Infraglottic Airway Management Devices, Laryngoscopes, Bronchoscope/Intubation Scopes and more), application (Anaesthesia, Emergency Medicine), material type (PVC (Polyvinyl Chloride) Airway Devices, Silicone Airway Devices) and end user (Hospitals, Homecare, Ambulatory Surgical Centres (ASCs)).
Who are the key players in the Airway Management Devices market?
Key players include Medtronic, Teleflex Inc, Ambu A/S, Smith’s Medical, Inc., Karl Storz SE & Co. KG and Flexicare (Group) Limited.
What is driving the Airway Management Devices market?
The prevalence of respiratory illnesses such as asthma, COPD, and obstructive sleep apnea warrants proper management of airway in order to facilitate adequate oxygenation.
Who regulates Airway Management Devices in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Airway Management Devices are running in the US?
318 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
How much research is published on Airway Management Devices?
PubMed lists 10,997 papers on Airway Management Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in US

See all

Related on emergency and acute care and respiratory

See the topic